Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. - Wikidata - wikimedia - TriplyDB

Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

http://www.wikidata.org/entity/Q34975040

about

CD14, endotoxin, and asthma risk: actions and interactions Evaluation of 15 functional candidate genes for association with chronic otitis media with effusion and/or recurrent otitis media (COME/ROM).Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/- mice The effect of perinatal anxiety on bronchiolitis is influenced by polymorphisms in ROS-related genes Innate signaling in otitis media: pathogenesis and recovery.Polymorphisms of immunity genes and susceptibility to otitis media in children.Exome sequencing identifies a missense mutation in Isl1 associated with low penetrance otitis media in dearisch mice Genome-wide association analysis reveals variants on chromosome 19 that contribute to childhood risk of chronic otitis media with effusion.Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.Unraveling the genetics of otitis media: from mouse to human and back again.Genetic susceptibility to otitis media in childhood.Current knowledge of the genetics of otitis media.The facial evolution: looking backward and moving forward.Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.NOD-Like Receptor Signaling in Cholesteatoma.Association of cytokine gene polymorphisms and risk factors with otitis media proneness in children.TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media.Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique.Differences of plasma IL-1 and TNF-α in healthy Chinese Population.

P2860

Q24648536-1B72A9B5-9B7D-4FC9-8CAD-46341FCE2D33 Q30431018-BE55DCA2-7936-49F6-9B85-4BE173F2D433 Q33382988-F3425D34-91FA-438A-B2E8-F2F680F72C68 Q33490848-3C3F2A0B-895F-4CA0-BE4A-1BBAB30FF265 Q34087825-96DB9D11-0B30-483C-829B-61B221054BD2 Q34334281-4F943EED-8EA4-4CDF-949A-D50DEAABD5D2 Q34486754-1E248C0D-55D2-424E-A47B-23C57037210B Q35144244-4372B892-605E-4343-AABF-9B4A5E8649F9 Q35840689-3523A0A3-F837-4B0A-80DC-3CF9898C87E4 Q37260776-4A9E4A5C-CEB7-4CFD-A38E-EDD319B1E5BA Q37497786-5D0B9298-175D-4DF2-8688-348AEC1FAA21 Q37812277-9D5768C3-C671-435C-B26D-8221EC7BBC40 Q37976616-4E63306A-C1AD-4489-89C7-5B8922AD624D Q38034091-7C693BAB-528A-4613-9A3E-22C270D44AF0 Q38049128-6B5B9AB4-49E4-49FD-AA3F-F644DB76A128 Q38413291-3AFF3445-9676-49DC-9E63-5611D5CB8C21 Q39682752-CD3F9952-2888-4841-9649-3124F1E78CE4 Q40762495-BC97079B-234F-40EC-85CF-07B922F593F8 Q41973607-4164CA00-1B01-488E-96F4-C2115AB32A32 Q46767323-1BF2577C-A608-46D3-8AF1-DEF5C8A6F271 Q54268444-086C8725-881B-4D07-B1B0-0564CBBB584E

P2860

Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

http://www.wikidata.org/entity/Q34975040

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Association of CD14 promoter p ...... neumococcal vaccine responses.

@ast

Association of CD14 promoter p ...... neumococcal vaccine responses.

@en

Association of CD14 promoter p ...... neumococcal vaccine responses.

@nl

type

label

Association of CD14 promoter p ...... neumococcal vaccine responses.

@ast

Association of CD14 promoter p ...... neumococcal vaccine responses.

@en

Association of CD14 promoter p ...... neumococcal vaccine responses.

@nl

prefLabel

Association of CD14 promoter p ...... neumococcal vaccine responses.

@ast

Association of CD14 promoter p ...... neumococcal vaccine responses.

@en

Association of CD14 promoter p ...... neumococcal vaccine responses.

@nl

P1433

Q34975040-6C1726C0-95D3-4D0C-BDDE-11ABC870860F

P1476

Q34975040-0AFE9B5D-9F22-425D-9107-29F142633233

P2093

Q34975040-176D0A0E-699E-4950-9EF6-D7E57D1E1083

Q34975040-404D02C8-D34D-4ED8-9415-55A0ACAC5CDB

Q34975040-6983D489-1579-404C-90AA-76F965DF09E5

Q34975040-7B25D6B1-4A77-4D7E-A4C0-48C92E054387

Q34975040-9E9F3252-4DBA-4A49-861E-BEB154E8CA22

Q34975040-A1F4AA9E-472B-44F4-820D-9F05EBCF3467

Q34975040-A794EC43-6BDA-4827-9A6F-E982079AD82E

Q34975040-B31EE3B6-C56C-4459-BE54-75A8FD6C2BE7

Q34975040-CB946A00-B528-49D8-BDC5-F18691FB6B4F

Q34975040-E00BD06B-607C-4A9C-A631-755B6D495B64

P2860

Q34975040-01CEFFD4-AD38-43A0-B7D0-28C3485AE20D

Q34975040-04FE45DE-5B43-4887-A9F7-D7181F597514

Q34975040-06C5324B-10C3-449B-8379-1A6340466A13

Q34975040-07E7CA2C-5773-44B2-9D50-77934230A96D

Q34975040-08BAA05D-C9B4-465B-BABC-0D89D0B9909A

Q34975040-0A569907-94E5-4439-A5D7-2159D032A1C5

Q34975040-0C4A9A8E-C10B-4818-8717-35494A46010C

Q34975040-0CFA2F70-B125-4ABD-A0FD-AF866764ED2F

Q34975040-0D67B8C4-2764-4561-87E1-40B51BD9183B

Q34975040-1F02CC3B-F627-4BF1-929E-BD7E0067F697

P304

Q34975040-BE863567-6FE5-4C0A-BA85-A773448428A5

P31

Q34975040-C9338F02-295D-4A8E-8990-55FC4E1B7B12

P356

Q34975040-5946B55B-7E7E-4224-A742-FC0C27BDA31B

P433

Q34975040-B9D2A57F-981D-407B-B22C-B82F89A78013

P478

Q34975040-D4D57C9F-24CC-42E6-BCE8-59C08733CCD4

P577

Q34975040-A2F8D16E-D545-4C7F-9E98-75A21DD1BC53

P698

Q34975040-AB4162AF-FFF2-424A-9738-455DE97AF604

P932

Q34975040-E2B4A76F-BB9E-4EE8-938F-7EF81A7F943F

P356

P1433

Clinical and Vaccine Immunology

P1476

Association of CD14 promoter p ...... neumococcal vaccine responses.

@en

P2093

E A M Sanders

http://www.w3.org/2001/XMLSchema#string

G A Zielhuis

http://www.w3.org/2001/XMLSchema#string

G Baynam

http://www.w3.org/2001/XMLSchema#string

G T Rijkers

http://www.w3.org/2001/XMLSchema#string

I A Laing

http://www.w3.org/2001/XMLSchema#string

J Goldblatt

http://www.w3.org/2001/XMLSchema#string

P N Lesouëf

http://www.w3.org/2001/XMLSchema#string

R H Veenhoven

http://www.w3.org/2001/XMLSchema#string

S P Wiertsema

http://www.w3.org/2001/XMLSchema#string

S-K Khoo

http://www.w3.org/2001/XMLSchema#string

P2860

CD14 is a cell-activating receptor for bacterial peptidoglycan

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium

Pyogenic bacterial infections in humans with IRAK-4 deficiency

Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children

Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades

Innate immunity: the virtues of a nonclonal system of recognition

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

P304

892-897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00100-06

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16893989

http://www.w3.org/2001/XMLSchema#string

P932

1539116

http://www.w3.org/2001/XMLSchema#string